Publications
Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management.
McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold GL
Aliment Pharmacol Ther. 2017; 00:1–17. https://doi.org/10.1111/apt.14384
Book chapter: Faecal Microbiota Transplantation as an Emerging Treatment in European Countries
Maida M, McIlroy J, Ianiro G, Cammarota G
In: Mastrantonio P, Rupnik M. (eds). Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology, vol 1050. Springer Cham.
Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK
Mcilroy JR, Nalagatla N, Hansen R, Hold G
Frontline Gastroenterologt 2018; 1-6. Doi:10.1136/flgastro-2017-100936
Current and future targets for faecal microbiota transplantation
J. Mcilroy, J.P. Segal, B.H. Mullish, M. Nabil Quraishi, A. Gasbarrini, G. Cammarota, G. Ianiro
Human Microbiome Journal (2018), doi: https://doi.org/10.1016/j.humic.2018.08.004
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?
McIlroy JR, Mullish BH, Goldenberg SD, Ianiro G, Marchesi JR
NCBI 2020 https://doi.org/10.1016/j.clim.2020.108542
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354373/
Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products
Mikkelsen TA, McIlroy JR, Mimiague M, Rouanet A, Sterkman L
United European Gastroenterology Journal 2020
https://doi.org/10.1177/2050640620910313
https://journals.sagepub.com/doi/full/10.1177/2050640620910313
Intestinal microbiota transfer - updating the nomenclature to increase acceptability
Craven LJ, McIlroy JR, Mullish BH, Marchesi JR
AP&T 2020 https://doi.org/10.1111/apt.16109
https://journals.sagepub.com/doi/full/10.1177/2050640620910313